메뉴 건너뛰기




Volumn 11, Issue 2, 2014, Pages 77-78

Cervical cancer in 2013: Screening comes of age and treatment progress continues

Author keywords

[No Author keywords available]

Indexed keywords

EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYSICIAN'S PRACTICE PATTERNS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84895908165     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.252     Document Type: Review
Times cited : (28)

References (9)
  • 1
    • 84884523437 scopus 로고    scopus 로고
    • Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions
    • Herfs, M. et al. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am. J. Surg. Pathol. 37, 1311-1318 (2013).
    • (2013) Am. J. Surg. Pathol. , vol.37 , pp. 1311-1318
    • Herfs, M.1
  • 2
    • 84862990363 scopus 로고    scopus 로고
    • A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer
    • Herfs, M. et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc. Natl Acad. Sci. USA 109, 10516-10521 (2012).
    • (2012) Proc. Natl Acad. Sci. USA , vol.109 , pp. 10516-10521
    • Herfs, M.1
  • 3
    • 84895909567 scopus 로고    scopus 로고
    • Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials
    • Ronco, G. et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. Lancet http://dx.doi.org/10.1016/S0140-6736(13)62218-7 (2013).
    • (2013) Lancet
    • Ronco, G.1
  • 4
    • 84876558188 scopus 로고    scopus 로고
    • Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer
    • Arbyn, M. et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30 (Suppl. 5), F88-F99 (2012).
    • (2012) Vaccine , vol.30 , Issue.SUPPL. 5 , pp. 88-99
    • Arbyn, M.1
  • 5
    • 84855301170 scopus 로고    scopus 로고
    • Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial
    • R ijkaart, D. C. et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial. Lancet Oncol. 13, 78-88 (2012).
    • (2012) Lancet Oncol. , vol.13 , pp. 78-88
    • Rijkaart, D.C.1
  • 6
    • 77649187281 scopus 로고    scopus 로고
    • Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial
    • Ronco, G. et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial. Lancet Oncol. 11, 249-257 (2010).
    • (2010) Lancet Oncol. , vol.11 , pp. 249-257
    • Ronco, G.1
  • 7
    • 84888264277 scopus 로고    scopus 로고
    • Effect of visual inspection with acetic acid (VIA) screening by primary health workers on cervical cancer mortality: A cluster randomized controlled trial in Mumbai India [abstract]
    • Shastri, S. S. et al. Effect of visual inspection with acetic acid (VIA) screening by primary health workers on cervical cancer mortality: A cluster randomized controlled trial in Mumbai, India [abstract]. J. Clin. Oncol. 31 (Suppl.), a2 (2013).
    • (2013) J. Clin. Oncol. , vol.31 , Issue.SUPPL. , pp. 2
    • Shastri, S.S.1
  • 8
    • 84884401355 scopus 로고    scopus 로고
    • Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group [abstract]
    • Tewari, K. S. et al. Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group [abstract]. J. Clin. Oncol. 31 (Suppl.), a3 (2013).
    • (2013) J. Clin. Oncol. , vol.31 , Issue.SUPPL. , pp. 3
    • Tewari, K.S.1
  • 9
    • 84881478416 scopus 로고    scopus 로고
    • From ASCO-Gynaecological cancer: Advances in cervical cancer screening and treatment
    • Kirk, R. From ASCO-Gynaecological cancer: Advances in cervical cancer screening and treatment. Nat. Rev. Clin. Oncol. 10, 425 (2013).
    • (2013) Nat. Rev. Clin. Oncol. , vol.10 , pp. 425
    • Kirk, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.